To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
Amulet to sell Synteract to Syneos Health
Amulet Capital Partners has agreed to sell its Synteract, a contract research organization for biotech and pharmaceutical companies.
